Intrexon Corp. (NYSE:XON) dropped 3% during mid-day trading on Monday . The stock traded as low as $24.30 and last traded at $25.34, with a volume of 2,037,426 shares. The stock had previously closed at $26.12.

XON has been the topic of several analyst reports. Vetr upgraded Intrexon Corp. from a “strong sell” rating to a “buy” rating and set a $27.01 price objective on the stock in a report on Thursday, July 28th. Griffin Securities reiterated a “buy” rating and issued a $55.00 target price on shares of Intrexon Corp. in a report on Tuesday, August 16th. JMP Securities assumed coverage on Intrexon Corp. in a report on Tuesday, May 3rd. They issued an “outperform” rating and a $42.00 target price on the stock. Zacks Investment Research cut Intrexon Corp. from a “strong-buy” rating to a “hold” rating in a report on Friday, May 6th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $57.00 target price on shares of Intrexon Corp. in a report on Wednesday, June 29th. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Intrexon Corp. presently has an average rating of “Buy” and an average target price of $41.71.

The company has a 50-day moving average price of $26.63 and a 200 day moving average price of $29.53. The company’s market cap is $3.01 billion.

Intrexon Corp. (NYSE:XON) last posted its quarterly earnings data on Tuesday, August 9th. The company reported ($0.42) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by $0.16. During the same period last year, the firm posted ($0.37) earnings per share. The firm had revenue of $52.50 million for the quarter, compared to the consensus estimate of $53.78 million. The company’s quarterly revenue was up 17.0% on a year-over-year basis. On average, equities analysts expect that Intrexon Corp. will post ($1.36) EPS for the current year.

An institutional investor recently raised its position in Intrexon Corp. stock. Bank of Montreal Can raised its position in shares of Intrexon Corp. (NYSE:XON) by 16.8% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 40,010 shares of the company’s stock after buying an additional 5,742 shares during the period. Bank of Montreal Can’s holdings in Intrexon Corp. were worth $1,207,000 at the end of the most recent reporting period.

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.